ÂÜÀòÂÒÂ×

Carmela Dantas-Barbosa has a diverse work experience in the field of bioscience and translational research. Carmela started their career as a Scientist at Sarah Network of Hospitals, where they designed and validated protocols for molecular diagnosis of various diseases. Carmela then worked as a Postdoctoral Research Fellow at CRBM - CNRS, where they developed a research project on differentially ubiquitylated proteins in leukemic cells. Subsequently, they worked as a Professor at the University Catholic of Goiás, Brazil.

Carmela then joined Institut Gustave Roussy in France as a Postdoctoral Research Fellow, where they conducted research on pediatric brain tumors and identified new therapeutic targets. Carmela also worked at Centre Léon Bérard as a Research Scientist, leading a team in the development and execution of target therapy research projects in leiomyosarcoma and gastrointestinal stroma tumors.

In 2016, Carmela joined Celgene as a Scientist I, contributing to the translational research team's efforts in the Epigenetics and Protein Homeostasis Thematic Center of Excellence. Carmela played a key role in developing and implementing methods for biomarker identification and testing of compounds through in vitro assays. Carmela also served as a Senior Associate Scientist, conducting early-stage drug development and collaborating with various functional areas.

Next, Carmela worked at Tizona Therapeutics, Inc. as a Scientist in the Antibody Development and Engineering team, where they focused on translating novel scientific insights into immunotherapies.

Most recently, Carmela held the role of Biomarkers and Companion Diagnostics Lead at Harpoon Therapeutics. As part of the Translational Medicine team, they played a significant role in developing biomarker strategies for immune-oncology programs and leading Harpoon CDx strategies.

Currently, Carmela is the Director of Translational Research at Mablink Bioscience, where they continue to contribute their expertise in translational research in the field of bioscience.

Carmela Dantas-Barbosa has a Master of Genetics and Immunology degree in Molecular Biology from the Universidade de Brasília. Furthermore, they also hold a Doctor of Philosophy (PhD) degree in Cell/Cellular and Molecular Biology from the same university. The exact start and end years of their education were not provided.